Skip to content

Hero image: A mother and clinician reviewing glucose results during a supportive postpartum appointment

All insights

Maternal and Metabolic Health

Gestational Diabetes Is a Lifelong Cardiometabolic Signal

10 min readEvidence synthesis
Read the evidence

The question in focus

A current evidence brief on gestational diabetes screening, pregnancy care, postpartum glucose testing and lifelong type 2 diabetes prevention.

Evidence at a glance

50% to 60%

estimated lifetime risk of diabetes after gestational diabetes

The ADA also reports an approximately tenfold relative risk compared with people without gestational diabetes. Risk is not destiny and varies with glycemia, weight trajectory, family history, recurrence and access to prevention. [1]

Management of Diabetes in Pregnancy: Standards of Care in Diabetes 2025

GDM identifies glucose intolerance during pregnancy

Gestational diabetes mellitus is hyperglycemia first recognized during pregnancy that does not meet criteria for overt diabetes identified early in pregnancy. Pregnancy increases insulin resistance, and some people cannot increase insulin secretion enough to maintain glucose within the target range. GDM often has no symptoms, so screening is central.

The ADA recommends screening for gestational diabetes at 24 to 28 weeks in people not previously found to have diabetes or high-risk early abnormal glucose metabolism. [2] Diagnostic strategies differ across jurisdictions. A result should be interpreted using the locally adopted, validated pathway rather than combining thresholds from different tests.

  • Distinguish overt pre-existing diabetes from GDM.
  • Use the health system's complete screening protocol.
  • Do not diagnose from a consumer glucose sensor alone.
  • Document the diagnosis for lifelong follow-up.

Treatment reduces pregnancy risk while respecting daily life

Management usually combines individualized nutrition support, safe physical activity, glucose monitoring and medication when targets are not met. Insulin is commonly used when pharmacologic treatment is needed, while recommendations for other medicines vary. Care should avoid moralizing food or body size and account for culture, nausea, work, food access and other medical conditions. [1][6]

Glucose targets and monitoring frequency are set by the maternity diabetes team. Fetal growth and maternal blood pressure may require additional surveillance because GDM is associated with macrosomia, birth injury, hypertensive disorders and neonatal metabolic complications. Treatment decisions balance maternal and fetal outcomes, treatment burden and the evidence for the specific medication. [1][6]

  • Use practical, culturally relevant nutrition planning.
  • Teach device technique and action thresholds.
  • Escalate medication without framing it as failure.
  • Coordinate delivery and postpartum medicine plans.

The postpartum test is time sensitive

The ADA recommends a fasting 75-gram oral glucose tolerance test at four to twelve weeks postpartum using nonpregnancy criteria. [1] The oral glucose tolerance test is preferred over HbA1c at that stage because pregnancy-related red-cell turnover and delivery blood loss can make HbA1c less reliable and because the glucose challenge is more sensitive for impaired glucose tolerance.

A normal early postpartum result does not end follow-up. The ADA recommends lifelong screening every one to three years. [1] The exact test and interval can reflect the postpartum result, additional risk factors and local guidance. A missed early test should prompt later testing, not abandonment of follow-up.

  • Book postpartum testing before maternity discharge.
  • Use the recommended oral glucose tolerance test in the early window.
  • Communicate the result to primary care.
  • Set the next screening date even when results are normal.

Risk accumulates across the life course

GDM can reveal underlying beta-cell vulnerability. ADA evidence estimates that absolute type 2 diabetes risk rises over decades and is higher after recurrent GDM. [1] The history is also associated with later cardiovascular risk. It should remain visible in the health record and be considered before future pregnancies.

Risk communication should use absolute and relative measures carefully. A tenfold relative increase does not mean every individual will develop diabetes, and a normal body size does not eliminate risk. Family history, ancestry, glycemic severity, subsequent weight trajectory, sleep, medication and social conditions all shape prevention opportunities.

  • Carry GDM into the permanent medical history.
  • Assess blood pressure and other cardiovascular risks.
  • Offer preconception glucose review before another pregnancy.
  • Do not restrict prevention to weight loss advice.

Prevention is effective when support is sustained

People with prior GDM and prediabetes can benefit from structured diabetes-prevention interventions focused on nutrition, activity and clinically appropriate weight management. Metformin may be considered in selected high-risk people according to diabetes-prevention guidance. The choice should account for breastfeeding, pregnancy plans, kidney function, tolerance and the individual's preference.

Breastfeeding is associated with lower maternal type 2 diabetes risk in observational evidence and is recommended for multiple maternal and infant benefits when desired and feasible. [1] It is not a substitute for screening, and people who cannot or choose not to breastfeed still deserve full prevention support without stigma.

  • Refer to an evidence-based prevention program when available.
  • Set achievable activity and nutrition goals.
  • Treat sleep, mental health and food access as metabolic-care issues.
  • Use medication selectively, with a named indication.

Close the maternity-to-primary-care gap

Postpartum testing rates are often limited by recovery, newborn care, transport, appointment design and fragmented records. Better systems order the test before discharge, send reminders, offer accessible laboratories, route results to a named clinician and create a registry for future screening. A reminder without capacity or follow-up is not a complete intervention. [4][6]

The goal is to convert a time-limited pregnancy diagnosis into useful prevention without making the patient carry the entire coordination burden. A structured record should include screening method, treatment during pregnancy, postpartum result, future testing date and preconception advice. That continuity supports the parent now and future pregnancies later. [1][4][6]

  • Name the clinician responsible for the result.
  • Use recall systems for lifelong screening.
  • Audit completion across language, geography and insurance status.
  • Integrate GDM history into future pregnancy and cardiovascular care.

What the evidence cannot yet answer

  • Lifetime diabetes estimates come from populations with different diagnostic criteria, follow-up and baseline risk.
  • Screening thresholds and one-step versus two-step strategies differ among health systems.
  • Breastfeeding associations are observational and may be affected by social and health differences.
  • Continuous glucose monitors can support selected care but do not replace validated diagnostic testing.

Questions worth taking into care

  1. Which diagnostic pathway and glucose targets is my maternity service using?
  2. When and where is my postpartum oral glucose tolerance test booked?
  3. Who will receive and explain the result?
  4. What is my next screening date if the early result is normal?
  5. Which prevention support fits my health, culture, resources and pregnancy plans?

Source record

Evidence used in this review

Sources were selected for clinical authority, methodological relevance and traceability. Links open the original guidance, public-health record or research publication.

  1. [1]
  2. [2]
  3. [3]
    Gestational Diabetes Screening Guidelines

    American Diabetes Association · 2025

  4. [4]
    Optimizing Postpartum Care

    American College of Obstetricians and Gynecologists · 2018

  5. [5]
  6. [6]
Editorial standard

This evidence synthesis is for general information. It does not diagnose a condition or replace care from a qualified health professional. Treatment choices depend on individual history, examination, local guidance and informed preference. Emergency or rapidly worsening symptoms need urgent local medical assessment.